WGS

GeneDx Holdings (WGS)

About GeneDx Holdings (WGS)

GeneDx Holdings Corp. is a rare disease diagnosis company, with a mission to empower everyone to live their healthiest life through genomics. The firm combines clinical expertise, advanced technology, and the power of GeneDx Infinity. This foundation powers GeneDx's ExomeDx and GenomeDx tests, enabling clinicians to deliver precise, fast, and actionable diagnoses. The Infinity also fuels discovery for biopharma with AI-driven genomic intelligence. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$170.87
52 Week Low
$32.21
Market cap
2.1B
Dividend yield
0.00%
Volume
153
Avg. volume
849,978
P/E ratio
-19.27

GeneDx Holdings News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$170.87
52 Week Low
$32.21
Market cap
2.1B
Dividend yield
0.00%
Volume
153
Avg. volume
849,978
P/E ratio
-19.27